Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey

Autor: Scott Beegle, Hyun Joo Kim, Joao A de Andrade, Mary M Salvatore, Anna J Podolanczuk, Amy Hajari Case, David L Hotchkin, Thomas Kaelin, Murali Ramaswamy, Carlos Remolina, Conan Tu

Publikováno v: BMJ Open Respiratory Research, Vol 10, Iss 1 (2023)

Introduction Timely diagnosis of interstitial lung disease (ILD) is limited by obstacles in the current patient pathway. Misdiagnosis and delays are common and may lead to a significant burden of diagnostic procedures and worse outcomes. This Delphi

Externí odkaz: https://doaj.org/article/cee399aabe624107a6bf0278d58434fa

Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry

Autor: Hyun J, Kim, Laurie D, Snyder, Megan L, Neely, Anne S, Hellkamp, David L, Hotchkin, Lake D, Morrison, Shaun, Bender, Thomas B, Leonard, Daniel A, Culver

Publikováno v: Lung. 200(1)

Purpose To assess the impact of concomitant emphysema on outcomes in patients with idiopathic pulmonary fibrosis (IPF). Methods The IPF-PRO Registry is a US registry of patients with IPF. The presence of combined pulmonary fibrosis and emphysema (CPF

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bff36404690536ff12e24b003c00cc1
https://pubmed.ncbi.nlm.nih.gov/34997268

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases

Autor: Dirk Skowasch, Vincent Cottin, Athol U. Wells, Takashi Ogura, Jong Sun Park, Hataya K. Poonyagariyagorn, Maria Otaola, Wim A. Wuyts, David L. Hotchkin, Anoop M. Nambiar, Nikhil Hirani

Publikováno v: Cottin, V, Hirani, N A, Hotchkin, D L, Nambiar, A M, Ogura, T, Otaola, M, Skowasch, D, Park, J S, Poonyagariyagorn, H K, Wuyts, W & Wells, A U 2018, ' Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases ', European Respiratory Review, vol. 27, no. 150, 180076 . https://doi.org/10.1183/16000617.0076-2018
European Respiratory Review, Vol 27, Iss 150 (2018)

Although these conditions are rare, a proportion of patients with interstitial lung diseases (ILDs) may develop a progressive-fibrosing phenotype. Progressive fibrosis is associated with worsening respiratory symptoms, lung function decline, limited

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fadd2629e2f1ff09fc21fead79156e3f
https://pubmed.ncbi.nlm.nih.gov/30578335

Baseline Lung Function Had No Effect on Long-Term Reduction in FVC Decline With Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Autor: David L. Hotchkin, Paul Mohabir, Wibke Stansen, Bruno Crestani, Kevin F. Gibson, Mitchell Kaye, Manuel Quaresma

Publikováno v: Chest. 152:A453

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c51f6e982624861b828f769ff8468ec0
https://doi.org/10.1016/j.chest.2017.08.480

Low birth weight and respiratory disease in adulthood: a population-based case-control study

Autor: William J. Ehlenbach, Jason W. Chien, Thomas D. Koepsell, Eric C. Walter, David L. Hotchkin

Publikováno v: American journal of respiratory and critical care medicine. 180(2)

Rationale: The proportion of low and very low birth weight births is increasing. Infants and children with a history of low and very low birth weight have an increased risk of respiratory illnesses, but it is unknown if clinically significant disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9d5435a1f53ebc2864d430294dd6f21
https://pubmed.ncbi.nlm.nih.gov/19578139